Indications and Purposes
| 1 Indications And Usage Zolinza ® Is Indicated For The Treatment Of Cutaneous Manifestations In Patients With Cutaneous T-Cell Lymphoma Who Have Progressive, Persistent Or Recurrent Disease On Or Following Two Systemic Therapies. Zolinza Is A Histone Deacetylase (Hdac) Inhibitor Indicated For The Treatment Of Cutaneous Manifestations In Patients With Cutaneous T-Cell Lymphoma (Ctcl) Who Have Progressive, Persistent Or Recurrent Disease On Or Following Two Systemic Therapies. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Vorinostat |
|
ZINC1543873 |